- Home
- BNTC vs ACTG Comparison
BNTC vs ACTG Comparison
Compare BNTC & ACTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNTC | ACTG |
|---|---|---|
| Founded | 1995 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Multi-Sector Companies |
| Sector | Health Care | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 454.2M | 438.5M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BNTC | ACTG |
|---|---|---|
| Price | $11.57 | $4.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $27.67 | $6.00 |
| AVG Volume (30 Days) | 120.0K | ★ 260.1K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 80.94 | ★ 161.11 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $12,004,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.85 | $3.12 |
| 52 Week High | $16.76 | $5.27 |
Technical Indicators
Market Signals| Indicator | BNTC | ACTG |
|---|---|---|
| Relative Strength Index (RSI) | 40.83 | 56.62 |
| Support Level | $11.40 | $4.53 |
| Resistance Level | $13.48 | $4.78 |
| Average True Range (ATR) | 0.71 | 0.13 |
| MACD | -0.25 | 0.03 |
| Stochastic Oscillator | 19.99 | 68.22 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations, and Manufacturing Operations. It derives revenue from the Intellectual Property Operations segment. Geographically, it operates in the Americas, Europe, the Middle East and Africa, China, India, and Asia-Pacific.